Clinitech Laboratory IPO vs Manglam Infra And Engineering IPO

Comparision between Clinitech Laboratory IPO and Manglam Infra And Engineering IPO.

IPO Details

Clinitech Laboratory IPO is a SME Book Built Issue IPO proposed to list at BSE SME while Manglam Infra And Engineering IPO is a SME Book Built Issue proposed to list at NSE SME.

	Clinitech Laboratory IPO	Manglam Infra And Engineering IPO
Logo
Issue Category	SME	SME
Issue Type	IPO	IPO
Process Type	Fixed Price Issue	Book Built Issue
Listing At	BSE SME	NSE SME
Lead Managers	Inventure Merchant Banker Services Pvt Ltd	Unistone Capital Pvt Ltd
Registrar	Bigshare Services Pvt Ltd	Bigshare Services Pvt Ltd
Market Maker	Svcm Securities Private Limited	Giriraj Stock Broking Private Limited
DRHP	DRHP	DRHP
RHP	RHP	RHP
Anchor Investor		Anchor Investor
IPO Allotment URL	IPO Allotment URL	IPO Allotment URL

Issue Size and Price

The total issue size of Clinitech Laboratory IPO is up to ₹5.78 Cr whereas the issue size of the Manglam Infra And Engineering IPO is up to ₹27.62 Cr. The final issue price of Clinitech Laboratory IPO is ₹96.00 per share and of Manglam Infra And Engineering IPO is ₹56.00 per share.

	Clinitech Laboratory IPO	Manglam Infra And Engineering IPO
Face Value	₹10 per share	₹10 per share
Issue Price (Lower)		₹53.00 per share
Issue Price (Upper)		₹56.00 per share
Issue Price (Final)	₹96.00 per share	₹56.00 per share
Discount (Retail)
Discount (Employee)
Market Lot Size	1200 shares	2000 shares
Fresh Issue Size	6,02,400 shares	49,32,000 shares
Fresh Issue Size (Amount)	up to ₹5.78 Cr	up to ₹27.62 Cr
OFS Issue Size
OFS Issue Size (Amount)
Issue Size Total	6,02,400 shares	49,32,000 shares
Issue Size Total (Amount)	up to ₹5.78 Cr	up to ₹27.62 Cr

IPO Timetable

Clinitech Laboratory IPO opens on Jul 25, 2024, while Manglam Infra And Engineering IPO opens on Jul 24, 2024. The closing date of Clinitech Laboratory IPO and Manglam Infra And Engineering IPO is Jul 29, 2024, and Jul 26, 2024, respectively.

	Clinitech Laboratory IPO	Manglam Infra And Engineering IPO
Anchor Bid Date		Jul 23, 2024
Issue Open	Jul 25, 2024	Jul 24, 2024
Issue Close	Jul 29, 2024	Jul 26, 2024
Basis Of Allotment (Tentative)	Jul 30, 2024	Jul 29, 2024
Initiation of Refunds (Tentative)	Jul 31, 2024	Jul 30, 2024
Credit of Share (Tentative)	Jul 31, 2024	Jul 30, 2024
Listing date (Tentative)	Aug 01, 2024	Jul 31, 2024
Anchor Lockin End date 1		Aug 28, 2024
Anchor Lockin End date 2		Oct 27, 2024

Financials

Clinitech Laboratory IPO P/E ratio is 43.45, as compared to Manglam Infra And Engineering IPO P/E ratio of 10.49.

Clinitech Laboratory IPO

Manglam Infra And Engineering IPO

Financial

Clinitech Laboratory Limited Financial Information (Restated)

Clinitech Laboratory Limited's revenue increased by 1.19% and profit after tax (PAT) dropped by -39.46% between the financial year ending with March 31, 2024 and March 31, 2023.

Period Ended	31 Mar 2024	31 Mar 2023	31 Mar 2022	31 Mar 2021
Assets	560.79	603.33	368.74	273.32
Revenue	643.92	636.34	645.70	459.63
Profit After Tax	37.12	61.31	51.26	40.24
Net Worth	354.80	238.08	184.81	139.03
Reserves and Surplus	186.80	88.08	34.81	72.37
Total Borrowing	86.31	102.91	88.61	53.67
Amount in ₹ Lakhs

Manglam Infra and Engineering Limited Financial Information (Restated)

Manglam Infra and Engineering Limited's revenue increased by 16.46% and profit after tax (PAT) rose by 22.06% between the financial year ending with March 31, 2024 and March 31, 2023.

Period Ended	31 Mar 2024	31 Mar 2023	31 Mar 2022
Assets	3,318.23	2,104.13	1,673.32
Revenue	4,050.79	3,478.14	2,678.36
Profit After Tax	676.41	554.16	332.96
Net Worth	1,710.20	1,025.95	778.69
Reserves and Surplus	443.73
Total Borrowing	447.31	225.91	186.91
Amount in ₹ Lakhs

Promoter Shareholding (Pre-Issue)

83.63%

100.00%

Promoter Shareholding (Post-Issue)

61.56%

P/E Ratio

43.45

10.49

Market Cap

₹21.91 Cr.

₹98.54 Cr.

ROE

49.44%%

ROCE

44.95%%

Debt/Equity

0.24

0.26

EPS

₹2.21

₹5.34

RoNW

10.46%%

49.44%%

Shares Offered

In the Clinitech Laboratory IPO retail investors (RII) are offered 3,01,200 shares while in Manglam Infra And Engineering IPO retail investors are offered 3,01,200 shares. Qualified institutional buyers (QIB) are offered 0 shares in Clinitech Laboratory IPO and 8,82,000 shares in Manglam Infra And Engineering IPO.

	Clinitech Laboratory IPO	Manglam Infra And Engineering IPO
Anchor Investor Reserveration		13,22,000 shares
Market Maker Reserveration	31,200 shares	5,24,000 shares
QIB	0 shares	8,82,000 shares
NII	3,01,200 shares	6,60,000 shares
RII	3,01,200 shares	15,44,000 shares
Employee	0 shares	0 shares
Others
Total	5,71,200 shares	30,86,000 shares

Bids Received (Subscription)

Clinitech Laboratory IPO subscribed 38.96x in total, whereas Manglam Infra And Engineering IPO subscribed 394.42x.

	Clinitech Laboratory IPO	Manglam Infra And Engineering IPO
QIB (times)		163.04x
NII (times)	23.28x	756.73x
Big NII (times)
Small NII (times)
RII (times)	49.61x	371.72x
Employee (times)
Other (times)
Total (times)	38.96x	394.42x

Compare with others

Clinitech Laboratory IPO	Manglam Infra And Engineering IPO
Esprit Stones IPO	Sathlokhar Synergys E&C Global IPO
S A Tech Software India IPO	Trom Industries IPO
Aprameya Engineering IPO	Esprit Stones IPO
Manglam Infra And Engineering IPO	S A Tech Software India IPO
Chetana Education IPO	Aprameya Engineering IPO
VVIP Infratech IPO	Chetana Education IPO
V.L.Infraprojects IPO	Clinitech Laboratory IPO
RNFI Services IPO	VVIP Infratech IPO
Macobs Technologies IPO	V.L.Infraprojects IPO
Kataria Industries IPO	RNFI Services IPO

Comments

Add a public comment...